Differential expression of a number of chemokines and their receptors has been demonstrated in both acute and chronic MS lesions, including monocyte chemotactic protein-1 (MCP-1 or CCL2) and macrophage inflammatory protein-1α (MIP1α or CCL3; Szczucinski and Losy 2007). The gene discussed is CCL2; the disease is myeloid sarcoma.